Fifteen different 18F-FDG PET/CT qualitative and quantitative parameters investigated as pathological response predictors of locally advanced rectal cancer treated by neoadjuvant chemoradiation therapy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 40, Issue 6, 2013, Pages 853-864

  Maffione, Anna Margherita ^a   Ferretti, Alice ^a   Grassetto, Gaia ^a   Bellan, Elena ^a   Capirci, Carlo ^a   Chondrogiannis, Sotirios ^a   Gava, Marcello ^a   Marzola, Maria Cristina ^a   Rampin, Lucia ^a   Bondesan, Claudia ^a   Colletti, Patrick M ^b   Rubello, Domenico ^a  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Locally advanced rectal cancer; Neoadjuvant chemoradiotherapy; PET CT; SUV; TLG; TRG

Indexed keywords

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADJUVANT CHEMORADIOTHERAPY; ADULT; ADVANCED CANCER; AREA UNDER THE CURVE; ARTICLE; CANCER CLASSIFICATION; CANCER PATIENT; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLYCOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; MULTIMODALITY CANCER THERAPY; NEOADJUVANT CHEMORADIATION THERAPY; RECTUM CANCER; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; TUMOR VOLUME; ADJUVANT THERAPY; AGED; CHEMORADIOTHERAPY; MULTIMODAL IMAGING; PATHOLOGY; RECEIVER OPERATING CHARACTERISTIC; RECTUM TUMOR; REPRODUCIBILITY; SCINTISCANNING; TREATMENT OUTCOME; VERY ELDERLY; DIAGNOSTIC USE;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; CHEMORADIOTHERAPY; FEMALE; FLUORODEOXYGLUCOSE F18; GLYCOLYSIS; HUMANS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; NEOADJUVANT THERAPY; RADIOPHARMACEUTICALS; RECTAL NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 84883460784     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-013-2357-3     Document Type: Article

References (42)

1. Delbeke D,Walker R. Colorectal Cancer ". In: Delbeke D, Israel O, editors. Hybrid PET/CT and SPECT/CT imaging. Springer; 2010. p.261-92.
2. Gil-delgado MA, Khayat D. Cancro del colon e del retto. In: Pollock RE, Doroshok JH, Khayat D, Nakao A, O'Sullivah B, editors. UICC manuale di oncologia clinica. Minerva medica; 2008, VIII ed. p. 511-29.
3. Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic- Jelic L, et al. EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355(11):1114-23. Erratum in: N Engl JMed. 2007;357(7):728.
4. De Paoli A, Chiara S, Luppi G, Friso ML, Beretta GD, Del Prete S, et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol. 2006;17(2):246-51.
5. Graf W, Dahlberg M, Osman MM, Holmberg L, Pählman L, Glimelius B. Short-term preoperative radiotherapy results in downstaging of rectal cancer: a study of 1316 patients. Radiother Oncol. 1997;43(2):133-7.
6. Rödel C, Martus P, Papadoupolos T, Füzesi L, Klimpfinger M, Fietkau R, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol. 2005;23(34):8688-96.
7. Rosenberg R, Nekarda H, Zimmermann F, Becker K, Lordick F, Hofler H, et al. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J Surg Oncol. 2008;97(1):8-13.
8. Medich D, McGinty J, Parda D, Karlovits S, Davis C, Caushaj P, et al. Preoperative chemoradiotherapy and radical surgery for locally advanced distal rectal adenocarcinoma: pathologic findings and clinical implications. Dis Colon Rectum. 2001;44(8):1123-8.
9. Habr-Gama A, Perez RO, Nadalin W, Nahas SC, Ribeiro Jr U, Silva E, et al. Long-term results of preoperative chemoradiation for distal rectal cancer correlation between final stage and survival. J Gastrointest Surg. 2005;9(1):90-9.
10. Valentini V, Coco C, Cellini N, Picciocchi A, Fares MC, Rosetto ME, et al. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int J Radiat Oncol Biol Phys. 2001;51(2):371-83.
11. 18F-FDG PET in patients with locally advanced rectal cancer previously treated with neoadjuvant radiochemotherapy. AJR Am J Roentgenol. 2006;187(2): W202-8.
12. Huh JW, Min JJ, Lee JH, Kim HR, Kim YJ. The predictive role of sequential FDG-PET/CT in response of locally advanced rectal cancer to neoadjuvant chemoradiation. Am J Clin Oncol. 2012;35(4):340-4.
13. Habr-Gama A, Perez RO, Nadalin W, Sabbaga J, Ribeiro Jr U, Silva e Sousa Jr AH, et al. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg. 2004;240(4):711-7.
14. Capirci C, Rubello D, Pasini F, Galeotti F, Bianchini E, Del Favero G, et al. The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery. Int J Radiat Oncol Biol Phys. 2009;74(5):1461-9.
15. Melton GB, LavelyWC, Jacene HA, Schulick RD, Choti MA,Wahl RL, et al. Efficacy of preoperative combined 18-fluorodeoxyglucose positron emission tomography and computed tomography for assessing primary rectal cancer response to neoadjuvant therapy. J Gastrointest Surg. 2007;11(8):961-9.
16. Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, et al. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur J Nucl Med Mol Imaging. 2007;34(10):1583-93.
17. Capirci C, Rubello D, Chierichetti F, Crepaldi G, Carpi A, Nicolini A, et al. Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET. Biomed Pharmacother. 2004;58(8):451-7.
18. Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50 Suppl 1:122S-50.
19. Costelloe CM, Chuang HH, Madewell JE, Ueno NT. Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer. 2010;1:80-92.
20. International Atomic Energy Agency. The role of PET/CT in radiation treatment planning for cancer patient treatment. Vienna: IAEA; 2008.
21. International Atomic Energy Agency. Appropriate use of FDGPET for the management of cancer patients. Vienna: IAEA; 2010.
22. Ferretti A, Bellan E, Gava M, Chondrogiannis S, Massaro A, Nibale O, et al. Phantom study of the impact of reconstruction parameters on the detection of mini- and micro-volume lesions with a low-dose PET/CT acquisition protocol. Eur J Radiol. 2012;81(11):3363-70.
23. Erselcan T, Turgut B, Dogan D, Ozdemir S. Lean body mass-based standardized uptake value, derived from a predictive equation, might be misleading in PET studies. Eur J Nucl Med Mol Imaging. 2002;29:1630-8.
24. 18F-FDG: standardized uptake values in normal tissues. J Nucl Med. 2004;45:784-8.
25. Stahl A, Ott K, Schwaiger M, Weber WA. Comparison of different SUV-based methods for monitoring cytotoxic therapy with FDG PET. Eur J Nucl Med Mol Imaging. 2004;31:1471-8.
26. Larson SM, Erdi Y, Akhurst T, Mazumdar M, Macapinlac HA, Finn RD, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging. The visual response score and the change in total lesion glycolysis. Clin Positron Imaging. 1999;2(3):159-71.
27. Lee JA. Segmentation of positron emission tomography images: some recommendations for target delineation in radiation oncology. Radiother Oncol. 2010;96(3):302-7.
28. Capirci C, Valvo F, Salviato S. Concurrent boost radiotherapy as preoperative treatment for locally advanced rectal carcinoma: a new beam arrangement. Tumori. 2002;88:325-30.
29. Capirci C, Polico C,Mandoliti G. Dislocation of small bowel volume within box pelvic treatment fields, using the new "Up Down Table" device. Int J Radiat Oncol Biol Phys. 2002;88:325-30.
30. Quirke P, Dixon MF. The prediction of local recurrence in rectal adenocarcinoma by histopathological examination. Int J Colon Dis. 1988;3:127-31.
31. Mandard AM, Dalibard F, Mandard JC, Marnay J, Henry-Amar M, Petiot JF, et al. Pathologic assessment of tumor regression after preoperative CRT of esophageal carcinoma. Clinicopathologic correlations. Cancer. 1994;73:2680-6.
32. Augestad KM, Lindsetmo RO, Stulberg J, Reynolds H, Senagore A, Champagne B, et al. International preoperative rectal cancer management: staging, neoadjuvant treatment, and impact of multidisciplinary teams. World J Surg. 2010;34:2689-700.
33. Deneke T, Rau B, Hoffmann KT. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? Eur Radiol. 2005;15:1658-66.
34. Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, et al. Biologic correlates of 18fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002;20:379-87.
35. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Rectal cancer. Table of Contents Discussion, Version 3.2013, table MS-16, www.nccn.org. Accessed 1 Sep 2012.
36. Erdi YE, Mawlawi O, Larson SM, Imbriaco M, Yeung H, Finn R, et al. Segmentation of lung lesion volume by adaptive PET image thresholding. Cancer. 1997;80 Suppl 12:2505-9.
37. Ippolito D, Monguzzi L, Guerra L, Deponti E, Gardani G, Messa C, et al. Response to neoadjuvant therapy in locally advanced rectal cancer: assessment with diffusion-weighted MR imaging and 18FDG PET/CT. Abdom Imaging. 2012;37:1032-40.
38. Guillem JG, Moore HG, Akhurst T, Klimstra DS, Ruo L, Mazumdar M, et al. Sequential preoperative fluorodeoxyglucosepositron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer. J Am Coll Surg. 2004;199(1):1-7.
39. Kristiansen C, Loft A, Berthelsen AK, Graff J, Lindebjerg J, Bisgaard C, et al. PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer. Dis Colon Rectum. 2008;51(1):21-5.
40. Martoni AA, Di Fabio F, Pinto C, Castellucci P, Pini S, Ceccarelli C, et al. Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer. Ann Oncol. 2011;22(3):650-6.
41. Shanmugan S, Arrangoiz R, Nitzkorski JR, Yu JQ, Li T, Cooper H, et al. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT. Ann Surg Oncol. 2012;19(7):2178-85.
42. Chennupati SK, Quon A, Kamaya A, Pai RK, La T, Krakow TE, et al. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Am J Clin Oncol. 2012;35(4):334-9.